In ccRCC, PSMA expression appeared to correlate with VEGFR-2 and PFGFR-β overexpression [20], and a repeated PSMA PET after 1 month of Sunitinib treatment was superior to conventional CT in detecting early treatment response in one mccRCC patient [21]. Here, FOLH1 is linked to nonpapillary renal cell carcinoma.